Applications of 2-Amino-5-Bromo-3-Nitropyridine in Industrial Manufacturing

As a dedicated manufacturer of 2-Amino-5-Bromo-3-Nitropyridine, we support specialized industrial clients globally with consistent material quality designed for critical downstream production. This intermediate holds a defined role in the synthesis of high-performance compounds across advanced fine chemical sectors. Below, we detail the most established commercial applications, highlighting industry regulations, real-world formulation details, integration steps, and manufactured end products.

1. Pharmaceutical Active Pharmaceutical Ingredient (API) Synthesis

Leading pharmaceutical companies rely on this pyridine derivative as a core building block in the multi-step synthesis of selective kinase inhibitors and anti-viral agents. Its halogenated and nitro functionalities enable reliable coupling and functional group manipulation during early-stage molecule assembly, especially in small molecule pipeline R&D and commercial scale-up.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice (GMP)
• 21 CFR Part 210/211 (US FDA)
• European Pharmacopoeia (Ph. Eur.) relevant monograph specifications
• China Pharmacopoeia for APIs

Typical usage ratio

• Batch formulations typically introduce the intermediate at 0.8–3.5% mol/mol relative to the primary starting material, adjusted based on target API complexity and impurity controls.

Downstream process integration

• Material enters as an early-stage precursor during Suzuki or Buchwald-Hartwig coupling processes or as a nucleophilic aromatic substitution substrate; purification proceeds by extraction and crystallization prior to downstream functionalization.

Final product types

• Oral tablet and capsule formulations (small molecule kinase inhibitors)
• Preclinical and clinical injectable agents (novel antiviral compounds)
• Patent-protected new molecular entities (NMEs) in oncology and infectious disease

2. Agrochemical Active Ingredient Intermediates

Global crop protection manufacturers integrate this compound for synthesizing pyridine-based insecticide and herbicide actives. Functionalization enables precise heterocyclic core modification to deliver targeted crop safety and pesticide selectivity profiles imperative in certified global agricultural supply chains.

Industry compliance standards

• OECD Guidelines for the Testing of Chemicals
• ISO 9001:2015 for chemical process control
• US EPA FIFRA regulations
• European Plant Protection Products Regulation (EC No 1107/2009)

Typical usage ratio

• Input levels range from 1.0–2.5% w/w in active ingredient precursor stages, tailored per molecule design for target field application rates and environmental residue regulations.

Downstream process integration

• Intermediate introduced during nitration or halogenation steps of heterocyclic API core formation; commonly follows with amidation or further cross-coupling to build diversity in agrochemical scaffolds.

Final product types

• Suspension concentrates (SC) and emulsifiable concentrates (EC) for crop spraying
• Granular pre-emergent herbicide actives
• Seed coating reagents with improved mode-of-action profiles

3. Dye & Pigment Intermediates for Electronic Display Materials

Electronics manufacturers source this compound for key pyridine-based dye intermediates, supporting the creation of advanced organic light-emitting diodes (OLED) and liquid crystal display (LCD) materials. Its electron-withdrawing groups enable efficient tuning of emissive behavior and color purity that meet rising industry specifications for display performance.

Industry compliance standards

• RoHS Directive (2011/65/EU) for hazardous substances
• IEC 62474 Material Declaration Standard
• JEDEC JESD709 for organic dye uniformity in displays
• ISO 14001 Environmental Management System for pigment synthesis

Typical usage ratio

• Dye intermediate syntheses incorporate the compound at a 0.5–1.5% w/w ratio in the core pyridine stage, with ratio optimization for chromophore intensity and display backplane compatibility.

Downstream process integration

• Compound introduced as a precursor during Friedel–Crafts acylation or amidation steps to assemble extended conjugation pathways; integration continues with dye purification and OLED/LCD backplane coating.

Final product types

• OLED pixel material components (R, G, B layers)
• Functional liquid crystal dyes for TFT-LCD panels
• High-brightness blue and green emission materials in displays

4. Fine Chemical Intermediates for Specialty Polymer Production

Polymer manufacturers leverage this pyridine derivative for functional monomer synthesis, providing halogen and nitro site reactivity needed for block copolymers with controlled conductivity, flame retardancy, and modified solubility. It offers tailored input for advanced engineering plastics and specialty resins.

Industry compliance standards

• ISO 9001:2015 Quality Management for polymers
• EN 14582 for flame retardant content
• REACH (EC 1907/2006) registration for monomers and intermediates
• UL 94 Flammability Standards for finished plastics

Typical usage ratio

• Blend ratios in monomer synthesis span 0.2–1.2% mol/mol, closely monitored via batch analytics and adapted for specific mechanical and safety property targets in the final polymer.

Downstream process integration

• The compound enters as a functional monomer precursor within condensation or copolymerization steps, commonly followed by chain extension, extrusion, and pelletization.

Final product types

• Antistatic engineering plastics for electronics housings
• Halogenated flame-retardant polymer granules
• Soluble specialty resins for custom coatings and adhesives

5. Veterinary Medicine Intermediate

Animal health API developers employ this chemical in the synthesis of selected veterinary drugs, specifically targeting the creation of active heterocyclic frameworks for parasite and bacterial control. The compound’s brominated and nitro character allows formulation chemists to construct highly-selective agents with improved bioavailability for livestock and companion animal applications.

Industry compliance standards

• VICH GL35 (GMP for active substances used as starting materials for veterinary drugs)
• US FDA 21 CFR Part 530 for extralabel drug use in animals
• European Medicines Agency (EMA) Regulations on veterinary pharmaceuticals
• ISO 17025 for analytical batch release

Typical usage ratio

• Used at 0.6–2.0% mol/mol in the active pharmaceutical synthesis phase, with adjustments based on species selectivity and final dosing requirements.

Downstream process integration

• Introduced in initial or mid-stage heterocycle assembly, typically through nucleophilic aromatic substitution or amidation; post-synthesis, intermediate is purified and derivatized for incorporation in veterinary dosage forms.

Final product types

• Oral suspensions and tablet APIs for livestock
• Antiparasitic chewables for companion animals
• Injectable formulations targeted at common veterinary infections